APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Zoster Vaccine Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchZoster Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zoster Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Zoster Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Zoster Vaccine market include GSK, Merck, SK chemicals, Sanofi Pasteur and Green Cross Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zoster Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zoster Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zoster Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zoster Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Zoster Vaccine Segment by Company

GSK

Merck

SK chemicals

Sanofi Pasteur

Green Cross Corp

Zoster Vaccine Segment by Type

Live Attenuated Vaccine

Recombinant

Zoster Vaccine Segment by Application

Government Institution

Private Sector

Other

Zoster Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Zoster Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Zoster Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zoster Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Zoster Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zoster Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zoster Vaccine industry.

Chapter 3: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Zoster Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Zoster Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zoster Vaccine Industry Trends Table 2. Zoster Vaccine Industry Drivers Table 3. Zoster Vaccine Industry Opportunities and Challenges Table 4. Zoster Vaccine Industry Restraints Table 5. Global Zoster Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zoster Vaccine Revenue Share by Company (2021-2026) Table 7. Global Zoster Vaccine Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Zoster Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Zoster Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Zoster Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Zoster Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Zoster Vaccine Company, Product Type & Application Table 13. Global Zoster Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Zoster Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Attenuated Vaccine Table 18. Significant Companies of Recombinant Table 19. Global Zoster Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Zoster Vaccine Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Zoster Vaccine Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Zoster Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Zoster Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Zoster Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zoster Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Zoster Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Zoster Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Zoster Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Government Institution Table 30. Significant Companies of Private Sector Table 31. Significant Companies of Other Table 32. Global Zoster Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Zoster Vaccine Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Zoster Vaccine Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Zoster Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Zoster Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Zoster Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Zoster Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Zoster Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Zoster Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Zoster Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Zoster Vaccine Sales by Region (2021-2026) & (W Units) Table 44. Global Zoster Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Zoster Vaccine Sales by Region (2027-2032) & (W Units) Table 46. Global Zoster Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Zoster Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Zoster Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Zoster Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Zoster Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Zoster Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Zoster Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Zoster Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Zoster Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 57. Global Zoster Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Zoster Vaccine Sales by Country (2027-2032) & (W Units) Table 59. Global Zoster Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Zoster Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Zoster Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Zoster Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Zoster Vaccine Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Zoster Vaccine Product Portfolio Table 68. GSK Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Merck Zoster Vaccine Product Portfolio Table 73. Merck Recent Development Table 74. SK chemicals Company Information Table 75. SK chemicals Business Overview Table 76. SK chemicals Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. SK chemicals Zoster Vaccine Product Portfolio Table 78. SK chemicals Recent Development Table 79. Sanofi Pasteur Company Information Table 80. Sanofi Pasteur Business Overview Table 81. Sanofi Pasteur Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Pasteur Zoster Vaccine Product Portfolio Table 83. Sanofi Pasteur Recent Development Table 84. Green Cross Corp Company Information Table 85. Green Cross Corp Business Overview Table 86. Green Cross Corp Zoster Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Green Cross Corp Zoster Vaccine Product Portfolio Table 88. Green Cross Corp Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Zoster Vaccine Distributors List Table 92. Zoster Vaccine Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Zoster Vaccine Product Image Figure 2. Global Zoster Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Zoster Vaccine Sales (2021-2032) & (W Units) Figure 5. Global Zoster Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Zoster Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Attenuated Vaccine Image Figure 10. Recombinant Image Figure 11. Global Zoster Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Zoster Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Zoster Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Zoster Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Zoster Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Zoster Vaccine Sales Value Share by Type (2021-2032) Figure 17. Government Institution Image Figure 18. Private Sector Image Figure 19. Other Image Figure 20. Global Zoster Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Zoster Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Zoster Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Zoster Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Zoster Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Zoster Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Zoster Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Zoster Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Zoster Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Zoster Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Zoster Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Zoster Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Zoster Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Zoster Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Zoster Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Zoster Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Zoster Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Zoster Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Zoster Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Zoster Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Recombinant
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Merck
  • SK chemicals
  • Sanofi Pasteur
  • Green Cross Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zoster Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Zoster Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Zoster Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Zoster Vaccine Market Dynamics
  1. 2.1 Zoster Vaccine Industry Trends
  2. 2.2 Zoster Vaccine Industry Drivers
  3. 2.3 Zoster Vaccine Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Industry Restraints
3 Zoster Vaccine Market by Company
  1. 3.1 Global Zoster Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Zoster Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Zoster Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Zoster Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Zoster Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Zoster Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Zoster Vaccine Company Product Type and Application
  8. 3.8 Global Zoster Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Zoster Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Zoster Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Zoster Vaccine Market by Type
  1. 4.1 Zoster Vaccine Type Introduction
  2. 4.1.1 Live Attenuated Vaccine
  3. 4.1.2 Recombinant
  4. 4.2 Global Zoster Vaccine Sales Volume by Type
  5. 4.2.1 Global Zoster Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zoster Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Zoster Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Zoster Vaccine Sales Value by Type
  9. 4.3.1 Global Zoster Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zoster Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Zoster Vaccine Sales Value Share by Type (2021-2032)
5 Zoster Vaccine Market by Application
  1. 5.1 Zoster Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Zoster Vaccine Sales Volume by Application
  6. 5.2.1 Global Zoster Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zoster Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Zoster Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Zoster Vaccine Sales Value by Application
  10. 5.3.1 Global Zoster Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Zoster Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Zoster Vaccine Sales Value Share by Application (2021-2032)
6 Zoster Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zoster Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Zoster Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Zoster Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Zoster Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Zoster Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Zoster Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Zoster Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Zoster Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Zoster Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Zoster Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Zoster Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Zoster Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Zoster Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Zoster Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Zoster Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Zoster Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Zoster Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Zoster Vaccine Sales Value Share by Country, 2025 VS 2032
7 Zoster Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Zoster Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zoster Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Zoster Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Zoster Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Zoster Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Zoster Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Zoster Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Zoster Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Zoster Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Zoster Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Zoster Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Zoster Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Zoster Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Zoster Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Zoster Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Zoster Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Zoster Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Zoster Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Zoster Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Zoster Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Zoster Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Zoster Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Zoster Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Zoster Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Zoster Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Zoster Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Zoster Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Zoster Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Zoster Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Zoster Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Zoster Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Zoster Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Zoster Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Zoster Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Zoster Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Zoster Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Zoster Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Zoster Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Zoster Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Zoster Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Zoster Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Zoster Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 SK chemicals
  14. 8.3.1 SK chemicals Company Information
  15. 8.3.2 SK chemicals Business Overview
  16. 8.3.3 SK chemicals Zoster Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SK chemicals Zoster Vaccine Product Portfolio
  18. 8.3.5 SK chemicals Recent Developments
  19. 8.4 Sanofi Pasteur
  20. 8.4.1 Sanofi Pasteur Company Information
  21. 8.4.2 Sanofi Pasteur Business Overview
  22. 8.4.3 Sanofi Pasteur Zoster Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pasteur Zoster Vaccine Product Portfolio
  24. 8.4.5 Sanofi Pasteur Recent Developments
  25. 8.5 Green Cross Corp
  26. 8.5.1 Green Cross Corp Company Information
  27. 8.5.2 Green Cross Corp Business Overview
  28. 8.5.3 Green Cross Corp Zoster Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Green Cross Corp Zoster Vaccine Product Portfolio
  30. 8.5.5 Green Cross Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zoster Vaccine Value Chain Analysis
  2. 9.1.1 Zoster Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zoster Vaccine Sales Mode & Process
  6. 9.2 Zoster Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zoster Vaccine Distributors
  9. 9.2.3 Zoster Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst